Itza V. Castro
Family · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Itza V. Castro’s office at (650) 853-2951 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$48,565
Medicare paid this office $48,565 for 236 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 218 | $39,286 | $91 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 208 | $4,364 | $12 |
| Telephone medical discussion with physician, 11-20 minutes | 35 | $3,091 | $64 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,374 | $106 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of trigger points, 1-2 muscles | – | 18 | 37 | – | – | – |
| Injection of trigger points, 3 or more muscles | – | 27 | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
236 Original Medicare patients in 2024. Average age 72 · Under 65 24% · 85 and older 14% · Women 73% · Also on Medicaid 32% · Health risk score 1.44. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 68% · Depression 42% · Diabetes 26% · Coronary heart disease 25% · Chronic kidney disease 22% · Heart failure 18% · COPD 18% · Atrial fibrillation 17% · Cancer 11% · Dementia 5% · Stroke 5%.
The office billed $196,727, Medicare allowed $69,405 and paid $48,565; for 855 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 236 | 855 | 72 | 1.44 | $196,727 | $48,565 |
| 2023 | 245 | 418 | 71 | 1.30 | $129,686 | $32,373 |
| 2022 | 324 | 866 | 71 | 1.30 | $272,471 | $79,386 |
| 2021 | 229 | 405 | 72 | 1.16 | $104,306 | $33,282 |
| 2020 | 102 | 236 | 76 | 1.10 | $61,211 | $16,515 |
| 2019 | 23 | 29 | 78 | 1.30 | $9,210 | $2,400 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 204 | $26,339 | $83 |
| Telephone medical discussion with physician, 11-20 minutes | 41 | $2,920 | $56 |
| Telephone medical discussion with physician, 21-30 minutes | 27 | $2,070 | $69 |
2022: 4 services
| Return visit (30+ min) | 305 | $67,420 | $99 |
| Telephone medical discussion with physician, 21-30 minutes | 63 | $7,833 | $102 |
| Short return visit (20+ min) | 74 | $3,018 | $39 |
| Telephone medical discussion with physician, 11-20 minutes | 24 | $839 | $34 |
2021: 6 services
| Return visit (30+ min) | 67 | $9,972 | $100 |
| Short return visit (20+ min) | 75 | $7,126 | $76 |
| Long return visit (40+ min) | 42 | $6,878 | $146 |
| Telephone medical discussion with physician, 11-20 minutes | 55 | $4,037 | $70 |
| Telephone medical discussion with physician, 21-30 minutes | 19 | $1,663 | $88 |
| Injection of trigger points, 1-2 muscles | 13 | $1,638 | $44 |
2020: 4 services
| Return visit (30+ min) | 80 | $10,201 | $84 |
| Telephone medical discussion with physician, 21-30 minutes | 29 | $2,611 | $82 |
| Injection of trigger points, 3 or more muscles | 13 | $1,394 | $52 |
| Injection of trigger points, 1-2 muscles | 12 | $792 | $44 |
2019: 1 service
| Return visit (30+ min) | 21 | $2,011 | $87 |
Medicaid work
$27 in 2023
Medicaid paid $27 for 13 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 13 | $27 |
| 2023 | 13 | 1 | 13 | $27 |
Drugs they prescribed that Part D paid
$299,778
Pharmacies billed $299,778 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 71% of their Part D prescriptions (1,836 of 2,590) in 2024. A higher opioid share than 9 in 10 peers; the typical nurse practitioner clinician is at 0%. Long-acting opioids: 30% of their opioid prescriptions.
2,261 generic and 329 brand-name prescriptions · $299,778 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Belbuca | 90 | $81,963 | $911 |
| Buprenorphine | 280 | $71,104 | $254 |
| Hydrocodone-Acetaminophen | 554 | $19,289 | $35 |
| Butrans | 41 | $18,690 | $456 |
| Oxycontin | 29 | $13,963 | $481 |
See all 28 drugs
| Belbuca | 90 | $81,963 | $911 |
| Buprenorphine | 280 | $71,104 | $254 |
| Hydrocodone-Acetaminophen | 554 | $19,289 | $35 |
| Butrans | 41 | $18,690 | $456 |
| Oxycontin | 29 | $13,963 | $481 |
| Oxycodone-Acetaminophen | 252 | $12,691 | $50 |
| Buprenorphine | 180 | $6,037 | $34 |
| Oxycodone | 217 | $4,990 | $23 |
| Buprenorphine-Naloxone | 35 | $3,641 | $104 |
| Pregabalin | 73 | $3,608 | $49 |
| Gabapentin | 126 | $2,686 | $21 |
| Hydromorphone | 116 | $2,177 | $19 |
| Fentanyl | 13 | $1,744 | $134 |
| Morphine Sulfate | 39 | $1,608 | $41 |
| Lidocaine | 12 | $1,502 | $125 |
| Naloxone | 22 | $1,279 | $58 |
| Morphine Sulfate Er | 42 | $1,228 | $29 |
| Cyclobenzaprine | 41 | $672 | $16 |
| Diclofenac | 23 | $587 | $26 |
| Methadone | 33 | $430 | $13 |
| Tramadol | 69 | $426 | $6 |
| Tizanidine | 29 | $385 | $13 |
| Baclofen | 12 | $334 | $28 |
| Celecoxib | 14 | $168 | $12 |
| Acetaminophen-Codeine | 12 | $148 | $12 |
| Clonazepam | 12 | $126 | $11 |
| Diazepam | 22 | $47 | $2 |
| Zolpidem | 13 | $42 | $3 |
Year by year
| 2024 | 2,590 | 642 | 71% (1,836) | 13% | $299,778 |
| 2023 | 2,472 | 588 | 67% (1,647) | 13% | $331,606 |
| 2022 | 4,332 | 718 | 76% (3,277) | 17% | $623,514 |
| 2021 | 1,929 | 598 | 78% (1,508) | 13% | $184,096 |
| 2020 | 405 | 108 | 66% (266) | 9% | $21,166 |
| 2019 | 75 | 47 | 71% (53) | None | $9,435 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 30 drugs
| Buprenorphine | 353 | $133,070 | $377 |
| Belbuca | 71 | $72,572 | $1,022 |
| Butrans | 31 | $26,752 | $863 |
| Hydrocodone-Acetaminophen | 473 | $18,400 | $39 |
| Oxycodone-Acetaminophen | 210 | $9,350 | $45 |
| Buprenorphine | 180 | $9,037 | $50 |
| Oxycontin | 17 | $8,748 | $515 |
| Gabapentin | 140 | $5,156 | $37 |
| Buprenorphine-Naloxone | 17 | $4,865 | $286 |
| Naloxone | 55 | $4,451 | $81 |
| Oxycodone | 165 | $3,973 | $24 |
| Pregabalin | 74 | $3,654 | $49 |
| Hydromorphone | 119 | $1,717 | $14 |
| Fentanyl | 20 | $1,435 | $72 |
| Tizanidine | 48 | $1,214 | $25 |
| Morphine Sulfate | 23 | $1,065 | $46 |
| Morphine Sulfate Er | 36 | $1,057 | $29 |
| Diclofenac | 23 | $953 | $41 |
| Tramadol | 51 | $732 | $14 |
| Cyclobenzaprine | 31 | $723 | $23 |
| Methadone | 37 | $655 | $18 |
| Baclofen | 22 | $520 | $24 |
| Duloxetine | 20 | $371 | $19 |
| Zolpidem | 15 | $357 | $24 |
| Celecoxib | 19 | $317 | $17 |
| Ondansetron Odt | 17 | $203 | $12 |
| Acetaminophen-Codeine | 14 | $175 | $12 |
| Sumatriptan | 12 | $130 | $11 |
| Ibuprofen | 19 | $104 | $5 |
| Diazepam | 13 | $59 | $5 |
2022: 34 drugs
| Buprenorphine | 539 | $216,144 | $401 |
| Belbuca | 121 | $96,921 | $801 |
| Butrans | 89 | $73,447 | $825 |
| Oxycontin | 51 | $39,417 | $773 |
| Hydrocodone-Acetaminophen | 995 | $36,610 | $37 |
| Buprenorphine | 314 | $20,871 | $66 |
| Oxycodone-Acetaminophen | 405 | $20,317 | $50 |
| Oxycodone | 385 | $13,018 | $34 |
| Xtampza Er | 14 | $9,077 | $648 |
| Pregabalin | 165 | $8,476 | $51 |
| Buprenorphine-Naloxone | 21 | $8,468 | $403 |
| Fentanyl | 49 | $4,848 | $99 |
| Hydromorphone | 217 | $4,400 | $20 |
| Lidocaine | 20 | $3,857 | $193 |
| Morphine Sulfate Er | 112 | $3,835 | $34 |
| Gabapentin | 122 | $3,578 | $29 |
| Naloxone | 24 | $2,307 | $96 |
| Morphine Sulfate | 44 | $2,039 | $46 |
| Methadone | 95 | $1,907 | $20 |
| Tramadol | 107 | $1,297 | $12 |
| Acetaminophen-Codeine | 24 | $1,172 | $49 |
| Butalbital-Acetaminophen-Caffe | 13 | $781 | $60 |
| Ondansetron Odt | 21 | $730 | $35 |
| Duloxetine | 23 | $656 | $29 |
| Hydroxyzine | 19 | $617 | $32 |
| Diclofenac | 24 | $600 | $25 |
| Cyclobenzaprine | 37 | $467 | $13 |
| Zolpidem | 19 | $424 | $22 |
| Tizanidine | 34 | $410 | $12 |
| Trazodone | 18 | $292 | $16 |
| Baclofen | 11 | $279 | $25 |
| Lorazepam | 18 | $271 | $15 |
| Naproxen | 13 | $145 | $11 |
| Diazepam | 26 | $127 | $5 |
2021: 22 drugs
| Buprenorphine | 137 | $49,403 | $361 |
| Hydrocodone-Acetaminophen | 502 | $19,551 | $39 |
| Belbuca | 24 | $18,945 | $789 |
| Butrans | 14 | $12,120 | $866 |
| Oxycontin | 27 | $11,779 | $436 |
| Oxycodone-Acetaminophen | 229 | $10,688 | $47 |
| Oxycodone | 213 | $6,243 | $29 |
| Buprenorphine | 80 | $4,499 | $56 |
| Pregabalin | 62 | $3,817 | $62 |
| Fentanyl | 32 | $2,866 | $90 |
| Hydromorphone | 118 | $2,786 | $24 |
| Morphine Sulfate Er | 53 | $1,879 | $35 |
| Narcan | 13 | $1,716 | $132 |
| Gabapentin | 74 | $1,340 | $18 |
| Methadone | 63 | $1,153 | $18 |
| Morphine Sulfate | 19 | $824 | $43 |
| Acetaminophen-Codeine | 11 | $620 | $56 |
| Baclofen | 13 | $613 | $47 |
| Tramadol | 42 | $390 | $9 |
| Cyclobenzaprine | 23 | $218 | $9 |
| Tizanidine | 14 | $187 | $13 |
| Diazepam | 24 | $138 | $6 |
2020: 11 drugs
| Hydrocodone-Acetaminophen | 137 | $5,300 | $39 |
| Oxycodone-Acetaminophen | 23 | $823 | $36 |
| Gabapentin | 39 | $671 | $17 |
| Oxycodone | 15 | $632 | $42 |
| Pregabalin | 14 | $624 | $45 |
| Methadone | 17 | $229 | $13 |
| Clonazepam | 12 | $133 | $11 |
| Cyclobenzaprine | 17 | $127 | $7 |
| Meloxicam | 19 | $92 | $5 |
| Acetaminophen-Codeine | 11 | $75 | $7 |
| Tramadol | 25 | $72 | $3 |
2019: 1 drug
| Hydrocodone-Acetaminophen | 26 | $781 | $30 |
Money from drug and device companies
$23 in 2024
| 2024 | 1 | 1 | None | $23 |
| 2023 | 1 | 1 | None | $15 |
| 2022 | 1 | 1 | None | $137 |
| 2021 | 1 | 1 | None | $66 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Botox | $23 | 1 payment
|
See the published payment
| Abbvie | Meals · 2024-10-26 | Botox | $23 |
See earlier years (2023, 2022, 2021)
2023: $15
| Collegium Pharmaceutical | Belbuca | $15 | 1 payment
|
2022: $137
| Medtronic | Accurian | $137 | 1 payment
|
2021: $66
| Si-Bone | Ifuse Implant | $66 | 1 payment
|
Professional record
- NPI
- 1780142737
- Licence
- CA 95010737
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2019-03-08
- NPI last updated
- 2020-06-03
- NPI record certified
- 2020-06-03
This is when the NPI record was last certified, not a medical board exam.